These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 10207770)

  • 1. Chairman's introduction--the importance of good quality surveillance data today.
    Grüneberg RN
    J Chemother; 1999 Feb; 11 Suppl 1():22-5. PubMed ID: 10207770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing the quality of the Alexander Project.
    Jacobs MR
    J Chemother; 1999 Feb; 11 Suppl 1():26-34. PubMed ID: 10207771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Alexander Project: the benefits from a decade of surveillance.
    Felmingham D; White AR; Jacobs MR; Appelbaum PC; Poupard J; Miller LA; Grüneberg RN
    J Antimicrob Chemother; 2005 Oct; 56 Suppl 2():ii3-ii21. PubMed ID: 16282278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in the antimicrobial susceptibility of bacterial respiratory tract pathogens--findings of the Alexander Project 1992-1996.
    Felmingham D; Washington J
    J Chemother; 1999 Feb; 11 Suppl 1():5-21. PubMed ID: 10207769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Alexander Project 1998-2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents.
    Jacobs MR; Felmingham D; Appelbaum PC; Grüneberg RN;
    J Antimicrob Chemother; 2003 Aug; 52(2):229-46. PubMed ID: 12865398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance patterns of Haemophilus influenzae.
    Acar JF
    J Chemother; 1999 Feb; 11 Suppl 1():44-50. PubMed ID: 10207773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Basing empiric treatment choices for respiratory tract infection on the results of the Alexander Project.
    Garau J
    J Chemother; 1999 Feb; 11 Suppl 1():51-5. PubMed ID: 10207774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial susceptibility of bacterial pathogens associated with community-acquired respiratory tract infections in Asia: report from the Community-Acquired Respiratory Tract Infection Pathogen Surveillance (CARTIPS) study, 2009-2010.
    Wang H; Chen M; Xu Y; Sun H; Yang Q; Hu Y; Cao B; Chu Y; Liu Y; Zhang R; Yu Y; Sun Z; Zhuo C; Ni Y; Hu B; Tan TY; Hsueh PR; Wang JH; Ko WC; Chen YH; Wahjono H
    Int J Antimicrob Agents; 2011 Nov; 38(5):376-83. PubMed ID: 21880469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial activity of a novel peptide deformylase inhibitor, LBM415, tested against respiratory tract and cutaneous infection pathogens: a global surveillance report (2003-2004).
    Watters AA; Jones RN; Leeds JA; Denys G; Sader HS; Fritsche TR
    J Antimicrob Chemother; 2006 May; 57(5):914-23. PubMed ID: 16549511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The need for antimicrobial resistance surveillance.
    Felmingham D
    J Antimicrob Chemother; 2002 Sep; 50 Suppl S1():1-7. PubMed ID: 12239224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimizing the management of community-acquired respiratory tract infections in the age of antimicrobial resistance.
    Doern GV
    Expert Rev Anti Infect Ther; 2006 Oct; 4(5):821-35. PubMed ID: 17140358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-duration therapy for respiratory tract infections.
    Goff DA
    Ann Pharmacother; 2004 Sep; 38(9 Suppl):S19-23. PubMed ID: 15226490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antimicrobial susceptibility of community-acquired respiratory tract pathogens isolated from patients in primary hospitals in Shanghai from 2007 to 2010].
    Zhou CM; Hu BJ; Gao XD; Bao R; Xie HM; Huang SL; Tao LL; He LX
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 May; 36(5):346-50. PubMed ID: 24047808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotic kinetic and dynamic attributes for community-acquired respiratory tract infections.
    Nicolau DP
    Am J Manag Care; 2000 Dec; 6(23 Suppl):S1202-10. PubMed ID: 11187444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotic susceptibility of pathogens isolated from patients with community-acquired respiratory tract infections in Pakistan--the active study.
    Zafar A; Hussain Z; Lomama E; Sibille S; Irfan S; Khan E
    J Ayub Med Coll Abbottabad; 2008; 20(1):7-9. PubMed ID: 19024175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global view of antimicrobial resistance. Findings of the SENTRY Antimicrobial Surveillance Program, 1997-1999.
    Pfaller MA; Jones RN
    Postgrad Med; 2001 Feb; 109(2 Suppl):10-21. PubMed ID: 19667553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial resistance in respiratory tract pathogens.
    Stratton CW
    Expert Rev Anti Infect Ther; 2004 Aug; 2(4):641-7. PubMed ID: 15482226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antibiotic resistance of S. pneumoniae and H. influenzae strains isolated from patients with community acquired respiratory tract infections. BACTRO multicenter, multidisciplinary study].
    Tudose C; Bumbăcea D; Bogdan M;
    Pneumologia; 2011; 60(1):30-5. PubMed ID: 21548198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of newer fluoroquinolones for respiratory tract infections and emerging patterns of antimicrobial resistance: data from the SENTRY antimicrobial surveillance program.
    Jones RN; Pfaller MA
    Clin Infect Dis; 2000 Aug; 31 Suppl 2():S16-23. PubMed ID: 10984323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meeting the challenge of antibiotic resistance: The PROTEKT US study.
    Stratton CW
    Postgrad Med; 2002 Sep; 112(3 Suppl):7-11. PubMed ID: 19667589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.